Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC’s Drug Discovery & Development of Innovative Therapeutics Conference
June 30, 2008
Debi wrote an interesting post today on
Here’s a quick excerpt
Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC
Life Sciences Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Boston & Seaport Hotel in Boston, MA. The cancer track presentations will focus on therapies for Hematology, Lung Cancer, Blood Borne Cancers, and Clinical Biomarkers.
Read the rest of this great post here
Posted in Research
